CD4 and COVID-19: Cytotoxic CD4+ T cells are detected more abundantly in older patients with mild COVID19 compared with those with severe COVID19 (Arthur et al., 2021), raising the possibility that these cells assist in antiviral immunity (Juno et al., 2017).